when did glp 1 agonists come out The Landscape Of GLP-1 Receptor In Diabetes And Obesity Treatment Navigating the -tides: Medication-Assisted Weight

(14) These emerging connections between GLP-1 signaling and skeletal physiology present a biologic rationale for how GLP-1 receptor agonists have potential to not only assist in weight management, but also favorably influence bone health and remodeling

50 A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults with Obesity (SURMOUNT-MMO) is due for completion in 2027 (clinical trial number NCT05556512)

After all, GLP-1 drugs are approved to be used as a supplement to, rather than a replacement for, healthy lifestyle changes

20 Sitagliptin is the only DPP-4 inhibitor to show significant reduction of BP

| CBS Evening News

GLP-1 side effects GLP-1 medications have a different side effect profile, heavily weighted toward gastrointestinal symptoms: Nausea (the most common, affecting 40-50% initially, but typically improving over weeks) Bloating and abdominal discomfort The key difference is trajectory